Sector |
|
Compare with Sector peers |
Industry |
|
Compare with Industry peers |
Website | http://www.nureca.com | |
Market Cap | 389.51 Cr. | |
Enterprise Value(EV) | 314.80 Cr. | 2022-09 |
Financial Indicators | ||
---|---|---|
Earnings per share (EPS) | -3.69 | Trailing Twelve Months Ending 2022-09 |
Price-Earning Ratio (PE) | - | Trailing Twelve Months Ending 2022-09 |
Industry PE | 58.81 | Trailing Twelve Months Ending 2022-09 |
Book Value / Share | 196.24 | Trailing Twelve Months Ending 2022-09 |
Price to Book Value | 1.99 | Calculated using Price: 390.00 |
Dividend Yield | 0.77 | Period Ending 2022-03 |
No. of Shares Subscribed | 1.00 Cr. | 10,000,175 Shares |
FaceValue | 10 | |
Company Profile | ||
Nureca is a B2C company engaged in the business of home healthcare and wellness products, which offers quality, durability, functionality, usability and innovative designs. It enables its customers with tools to help them monitor chronic ailments and other diseases, to improve their lifestyle. It is a digital first company wherein it sells its products through online channel partners such as e-commerce players, distributors and retailer. Further, it also sells its products through its own website drtrust.in. |
1 Day |
|
-11.35% |
1 Week |
|
-2.94% |
1 Month |
|
-22.57% |
3 Month |
|
-50.32% |
6 Month |
|
-62.15% |
1 Year |
|
-78.38% |
2 Year |
|
|
5 Year |
|
|
10 Year |
|
5 years | 2018-03 | 2019-03 | 2020-03 | 2021-03 | 2022-03 | |
Return on Equity (%) | 426.30 | 162.03 | 61.23 | 52.39 | 24.55 | |
Return on Capital Employed (%) | 255.06 | 179.97 | 56.70 | 67.61 | 33.48 | |
Return on Assets (%) | 44.35 | 40.78 | 22.30 | 41.38 | 20.33 |
Particulars | 6 years | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2022-09* Rs. Cr. |
Shh. Funds | 2 | 8 | 15 | 163 | 203 | 196 | |
Non Curr. Liab. | 0 | 0 | 9 | 3 | 4 | 1 | |
Curr. Liab. | 5 | 15 | 10 | 24 | 45 | 11 | |
Minority Int. | |||||||
Equity & Liab. | 7 | 24 | 34 | 190 | 252 | 209 | |
Non Curr. Assets | 0 | 1 | 1 | 4 | 13 | 12 | |
Curr. Assets | 7 | 23 | 33 | 186 | 239 | 197 | |
Misc. Exp. not W/O | |||||||
Total Assets | 7 | 24 | 34 | 190 | 252 | 209 |
Particulars | 6 years | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2022-09 Rs. Cr. TTM |
Net Sales | 20 | 62 | 99 | 213 | 256 | 151 | |
Other Income | 0 | 0 | 0 | 3 | 8 | 7 | |
Total Income | 20 | 62 | 99 | 216 | 263 | 158 | |
Total Expenditure | -16 | -53 | -90 | -152 | -200 | -160 | |
PBIDT | 4 | 9 | 10 | 64 | 63 | -2 | |
Interest | 0 | 0 | -1 | -2 | -1 | -1 | |
Depreciation | 0 | 0 | 0 | 0 | -1 | -2 | |
Taxation | -1 | -3 | -2 | -16 | -16 | 1 | |
Exceptional Items | |||||||
PAT | 3 | 6 | 6 | 46 | 45 | -4 | |
Minority Interest | |||||||
Share Associate | |||||||
Other Related Items | |||||||
Consolidated Net Profit | 3 | 6 | 6 | 46 | 45 | -4 | |
Adjusted EPS | 445 | 889 | 914 | 46 | 45 | -4 |
Particulars | 5 years | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. |
Cash Fr. Operatn. | 0 | 0 | -8 | 35 | 1 | |
Cash Fr. Inv. | 0 | 0 | 0 | -110 | -3 | |
Cash Fr. Finan. | 0 | 0 | 8 | 92 | -7 | |
Net Change | 0 | 0 | 0 | 17 | -9 | |
Cash & Cash Eqvt | 0 | 0 | 0 | 17 | 8 |
Fri, 27 Jan 2023
Board Meeting Intimation for Notice Of Board Meeting Nureca Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 03/02/2023 inter alia to consider and approve unaudited Financial Results (Standalone and Consolidated) of the Company for the quarter and nine months ended December 31 2022. |
Sat, 31 Dec 2022
Closure of Trading Window Trading Window for dealing in the equity shares of the Company will remain closed from January 01 2023 till 48 hours after the declaration of unaudited financial results of the Company for the period ended on December 31 2022. |
Mon, 26 Dec 2022
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011 The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Payal Goyal |
Fri, 27 Jan 2023 |
|
|
|
|
|